Skip to content

Effects of Ocular Electroacupuncture on Oculomotor Nerve Palsy

A Randomized Trial of Ocular Electroacupuncture for Oculomotor Nerve Palsy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03099447
Enrollment
177
Registered
2017-04-04
Start date
2017-04-06
Completion date
2019-07-25
Last updated
2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oculomotor Nerve Palsy

Keywords

electroacupuncture, oculomotor nerve palsy, rehabilitation, diplopia, ocular motility disorder

Brief summary

The purpose of the study is to testify the efficacy of treating oculomotor nerve palsy with ocular electroacupuncture or ocular acupuncture, and to compare the efficacy between these two interventions.

Detailed description

The purpose of the study is to testify whether ocular electroacupuncture or ocular acupuncture is effective for oculomotor nerve palsy (ONP), through treating ONP patient for 6 weeks, using self-invented acupoints according to anatomy of extraocular muscles innervated by oculomotor nerve, and using sham acupuncture as controlled group, and try to provide clinical evidence for promoting these new techniques.

Interventions

During intervention period, patients will continue to keep medications for primary condition. Patient's skin located in the extraocular muscles projection area is routinely disinfected. A diameter of 0.20 mm and length of 25 mm needle is inserted slowly. Piercing depth is about 20mm. The electropuncture apparatus is used, each group of electrodes are distinguished with different colors of wires to generate current stimulations of current 1.0\ 1.5 milliampere (mA), voltage 9 volt(V), frequency 1.5 hertz (Hz), and duration of 40 minutes.

During intervention period, patients will continue to keep medications for primary condition. Patient's skin located in the extraocular muscles projection area is routinely disinfected. A diameter of 0.20 mm and length of 25 mm needle is inserted slowly. Piercing depth is about 20mm.The duration of intervention is 40 minutes.

OTHERsham acupuncture

During intervention period, patients will continue to keep medications for primary condition. Patient's skin located in the extraocular muscles projection area is routinely disinfected. A diameter of 0.20 mm and length of 25 mm sham needle set is stick onto insertion area without piercing into the skin. The duration of intervention is 40 minutes.

Sponsors

First Affiliated Hospital of Harbin Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

; 1. patient with confirmed diagnosis of complete oculomotor nerve palsy (with or without mydriasis) made by neurologist or ophthalmologist; 2. patient in stable condition after treatment for primary disease; 3. age between 18 to 80 years old without gender limitation; 4. haven't received acupuncture intervention for ONP before; 5. patient with conscious, willing to cooperate and voluntarily agreed to participate and signed informed consent forms.

Exclusion criteria

1. those with other diagnosed medical conditions known to contribute to ONP symptoms, such as thyroid disease, myasthenia gravis, mitochondrial myopathy, congenital strabismus or received strabismus surgery; 2. those with color blindness, dyschromatopsia or abnormal retinal correspondence couldn't complete computerized diplopia test; 3. those with serious medical conditions that might limit their participation; 4. those with eye or other location with serious infections; 5. women who had a positive pregnancy test or who were planning to become pregnant during the study period; 6. those with bleeding tendency, blood coagulation dysfunction or taken anticoagulant drugs; 7. who had participate in other clinical trials, which may affect the results.

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Ocular motor nerve function subscale at 6 Weeks6 weekThe patient will receive grading of eyelid lifting, eyeball inward, upward and downward moving ability by investigator. A total score will be summed up.The changes from baseline will be recorded.

Secondary

MeasureTime frameDescription
Angle of diplopia deviation6 weekPatients will receive computerized diplopia test with the guidance from an investigator. The data will be generated by the software automatically.
Eyeball movement distance6 weekThe distances of eyeball movement in inward, upward and downward direction and height between eyelids will be measured. The differences between affected and healthy eye will be calculated.
The quality of life questionnaire for ocular motor nerve palsy6 weekThe patients will finish a questionnaire to evaluate their physical and psychological status during this trial.

Countries

China

Contacts

Primary ContactLingYun Zhou, PhD
no1zhly@163.com+86 13351113936
Backup ContactTieJuan Liu, PhD
ltj850722@126.com+86 13946062207

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026